Kazuhisa Nakano

Kurashiki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 116 publications

Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy.

Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy.

Journal: ESMO gastrointestinal oncology

Published: April 17, 2026

Pulmonary alveolar proteinosis developing during tofacitinib treatment for anti-MDA5 antibody-positive dermatomyositis-associated interstitial lung disease: a case report and review of the literature.

Pulmonary alveolar proteinosis developing during tofacitinib treatment for anti-MDA5 antibody-positive dermatomyositis-associated interstitial lung disease: a case report and review of the literature.

Journal: Immunological medicine

Published: February 06, 2026

A case of concurrent cold agglutinin disease and C3 glomerulonephritis requiring differentiation from other iatrogenic immunodeficiency-associated lymphoproliferative disorder in a patient with rheumatoid arthritis and Sjögren's disease.

A case of concurrent cold agglutinin disease and C3 glomerulonephritis requiring differentiation from other iatrogenic immunodeficiency-associated lymphoproliferative disorder in a patient with rheumatoid arthritis and Sjögren's disease.

Journal: Immunological medicine

Published: January 21, 2026

Author Correction: GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region.

Author Correction: GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region.

Journal: Nature communications

Published: January 19, 2026

GAVE in Systemic Sclerosis with Concurrent Autoimmune Gastritis.

GAVE in Systemic Sclerosis with Concurrent Autoimmune Gastritis.

Journal: Internal medicine (Tokyo, Japan)

Published: January 14, 2026

Comment on: NK cell cytotoxicity is markedly reduced in younger patients with rheumatoid arthritis treated with JAK inhibitors: Reply.

Comment on: NK cell cytotoxicity is markedly reduced in younger patients with rheumatoid arthritis treated with JAK inhibitors: Reply.

Journal: Rheumatology (Oxford, England)

Published: July 07, 2025

Switching to IL-6 inhibitors or abatacept in elderly patients with rheumatoid arthritis achieving low disease activity with JAK inhibitors: a pilot study.

Switching to IL-6 inhibitors or abatacept in elderly patients with rheumatoid arthritis achieving low disease activity with JAK inhibitors: a pilot study.

Journal: Rheumatology (Oxford, England)

Published: May 23, 2025

Coexistence of IgG4-Related Disease and Renal Anastomosing Hemangioma: A Rare Diagnostic Challenge.

Coexistence of IgG4-Related Disease and Renal Anastomosing Hemangioma: A Rare Diagnostic Challenge.

Journal: Internal medicine (Tokyo, Japan)

Published: May 21, 2025

NK cell cytotoxicity is markedly reduced in younger patients with RA treated with JAK inhibitors.

NK cell cytotoxicity is markedly reduced in younger patients with RA treated with JAK inhibitors.

Journal: Rheumatology (Oxford, England)

Published: March 14, 2025

Clinical Significance of Antinuclear Antibodies in Patients with Rheumatoid Arthritis: From SETOUCHI-RA Registry.

Clinical Significance of Antinuclear Antibodies in Patients with Rheumatoid Arthritis: From SETOUCHI-RA Registry.

Journal: Journal of clinical medicine

Published: January 29, 2025

Case Report: Effective Management of Pulmonary Hypertension Associated With Takayasu Arteritis Through Both Immunosuppressive Therapy and Serial Balloon Pulmonary Angioplasty.

Case Report: Effective Management of Pulmonary Hypertension Associated With Takayasu Arteritis Through Both Immunosuppressive Therapy and Serial Balloon Pulmonary Angioplasty.

Journal: International journal of rheumatic diseases

Published: December 26, 2024

Prognosis and prognostic factors of lung cancer complications in patients with rheumatoid arthritis.

Prognosis and prognostic factors of lung cancer complications in patients with rheumatoid arthritis.

Journal: International journal of rheumatic diseases

Published: October 13, 2023

Showing 1-12 of 116

Last Updated: 09/26/2026